The trabecular meshwork (TM), a tissue residing in the iridocorneal angle of the eye, is the primary site of aqueous humor outflow and often develops abnormally in children with anterior segment dysgenesis (ASD). However, the cellular mechanisms underlying both normal and pathophysiological TM formation are poorly understood. Here, we improve the characterization of TM development via morphological and molecular analyses. We first assessed the TM of wild-type C57BL/6J mice at multiple time points throughout development (E15.5-P21). The morphology of TM cells, rate of cell division, presence of apoptotic cell death, and age of onset of an established TM marker (αSMA) were each assessed in the developing iridocorneal angle. We discovered that TM cells are identifiable histologically at P1, which coincided with both the onset of αSMA expression and a significant decrease in TM precursor cell proliferation. Significant apoptotic cell death was not detected during TM development. These findings were then used to assess two mouse models of ASD. Jag1 and Bmp4 heterozygous null mice display ASD phenotypes in the adult, including TM hypoplasia and corneal adherence to the iris. We further discovered that both mutants exhibited similar patterns of developmental TM dysgenesis at P1, P5, and P10. Our data indicate that P1 is an important time point in TM development and that TM dysgenesis in Jag1 and Bmp4 heterozygous null mice likely results from impaired TM cell migration and/or differentiation.
Introduction
Anterior segment dysgenesis (ASD) comprises a group of phenotypically variable diseases affecting the anterior-most tissues of the eye (Gould and John, 2002) . One of the most prevalent phenotypes observed in children with ASD is an attachment of the iris to the cornea (iridocorneal adhesion), which can impede aqueous humor efflux through the conventional trabecular meshwork (TM) outflow pathway (Gould et al., 2004) . This impediment can subsequently result in elevated intraocular pressure (IOP) and put the affected individual at an increased risk for developing glaucoma (Gould et al., 2004) . It is not known, however, whether iridocorneal adhesions result from a malformation of TM, iris, and/or corneal tissue, or whether the TM cannot form due to the adhesion obstructing cell migration and/or inductive signals. TM hypoplasia and iridocorneal adhesions are observed in mouse models of ASD as well (Chang et al., 2001; Gould et al., 2007; McKeone et al., 2011; Smith et al., 2000) , though the cellular perturbations that give rise to this tissue dysgenesis remain poorly understood. In order to elucidate the cause(s) and mechanism(s) of improper TM formation in ASD, we must first improve our understanding of the cellular and molecular milestones of normal TM development. Tissues of the anterior segment arise from multiple embryonic derivatives: the lens develops from surface ectoderm, the ciliary body from neural epithelium, Schlemm's canal from mesoderm, and the TM from neural crest cells (Gage et al., 2005; Heavner and Pevny, 2012) . Precise interaction between these tissues is essential for ocular development to proceed properly. However, this complex interplay renders the study of individual structures, such as the TM, fairly difficult. Though the cellular and molecular aspects of TM development are almost completely unknown, some aspects of its morphological development have been studied. The TM is one of the last anterior segment structures to develop, with the area originally occupied by a dense mass of undifferentiated mesenchymal neural crest cells migrating from the https://doi.org/10.1016/j.exer.2018.02.011 Received 23 September 2017; Received in revised form 12 January 2018; Accepted 12 February 2018 neural tube (Abu-Hassan et al., 2014) . These cells begin to elongate and separate, forming the characteristic beam-like structures of the more mature TM . However, to our knowledge, no one has pinpointed the time at which TM progenitor cells undergo differentiation or how the intertrabecular spaces are formed-be it from apoptotic pruning or extracellular matrix (ECM) remodeling.
Aside from the complex interplay between cell and tissue types throughout anterior segment development, several other features make the mouse TM challenging to study: the tissue is extremely small and delicate, it has a relatively acellular composition consisting mainly of ECM, and no known markers specific to differentiated TM cells have been identified (Fautsch, 2006; Sathiyanathan et al., 2017) . These endothelial-like cells exist amongst trabecular beams comprised of collagen, laminin, fibronectin, and elastin (Fautsch, 2006) . The TM is further subdivided into three layers: the uveal meshwork (inner-most portion), the corneoscleral meshwork (middle portion), and the juxtacanalicular meshwork (adjacent to Schlemm's canal), thought to be responsible for aqueous humor outflow resistance (Llobet et al., 2003) . Because of the contractile nature of the TM, α-smooth muscle actin (αSMA) is a common marker with which to identify the adult TM tissue (however, it also labels the adjacent ciliary muscle and nearby iris musculature) (Davis et al., 2009; de Kater et al., 1992; Ko and Tan, 2013) . The onset of αSMA expression -potentially indicating an important TM cellular differentiation stage -has yet to be identified.
We first analyzed wild-type C57BL/6J mice to assess changes in morphology, proliferation, apoptotic cell death, and αSMA expression at multiple time points throughout TM development. Using these findings, we then assessed two mouse models of ASD: Bmp4 heterozygous null mice (Chang et al., 2001 ) and Jag1 heterozygous null mice (Kiernan et al., 2007) to investigate the timing and mechanism(s) of TM hypoplasia and iridocorneal adhesions.
Materials and methods

Mice
C57BL/6J mice were used for all wild-type TM development experiments. Bmp4 mutant mice (referred to as Bmp4 Δ/+ ) were created by mating a ubiquitously expressed CMV-Cre (Schwenk et al., 1995) to a mouse carrying two floxed alleles of Bmp4 (Liu et al., 2004) , resulting in a germline deletion of one copy of Bmp4. Jag1 mutant mice (referred to as Jag1 Δ/+ ) (Xue et al., 1999) have been previously described. Crenegative littermates were used as controls in each experiment. Housing and handling of animals was performed in accordance with the Association for Research in Vision and Ophthalmology's statement on the use of animals in ophthalmic research and approved by the Committee on Animal Resources at The University of Rochester Medical Center.
Tissue processing and histology
For cryoprotected frozen sections, E15.5-P10 animals were decapitated and whole heads were fixed in 4% paraformaldehyde in 1XPBS for 24 hours. Heads were rinsed in 1X PBS and submerged in a 10%, 20%, 30% sucrose gradient before embedding in tissue freezing medium. Eyes from mice P21 or older were enucleated and fixed in 4% paraformaldehyde in 1XPBS for two hours. The posterior segment was removed just below the limbus and the lens extracted. Eyes were then submerged in 30% sucrose for 2 days at 4°C prior to embedding in tissue freezing medium. Both heads and eyes were sectioned at 14μ (HM550 Microm Cryostat), and prepared for immunohistochemistry. For plastic sections, E15.5 and E17.5 embryos were decapitated, and eyes from postnatal animals were enucleated immediately after euthanasia. Both heads and eyes were fixed in 2.5% paraformaldehyde; 2% glutaraldehyde in 1XPBS overnight at room temperature. Heads and R.L. Rausch et al. Experimental Eye Research 170 (2018) [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] eyes were left intact, dehydrated with a series of ethanol washes, embedded in Technovit 7100 hardener (Kulzer), sectioned at 2.5μ (HM 355S Automatic Microtome), and stained with hematoxylin and eosin (Multiple Stain Solution, Polysciences).
Immunohistochemistry
Cryo-sections were blocked for two hours with 10% horse serum in 0.1% Triton-X in 1XPBS followed by primary antibody staining with mouse anti-α-smooth muscle actin (Chemicon International) at a concentration of 1:100, rabbit anti-Ki67 (abcam) at a concentration of 1:500, or rabbit anti-cleaved caspase3 (R&D Systems) at a concentration of 1:1000 overnight at 4°C. Secondary antibodies conjugated with either donkey anti-mouse Alexa Fluor 488 or donkey anti-rabbit Alexa Fluor 555 (Thermo Fisher Scientific) were used at a concentration of 1:1000 for two hours at room temperature. Three 15-min 1XPBS washes were performed between antibody incubations. Fluorescent images were visualized and photographed on a Zeiss M1 Epifluorescent Fig. 2 . TM precursor cell division decreases postnatally. Pregnant C57BL/6J dams or perinatal pups were injected with BrdU and sacrificed either 2 h post injection (A), or aged to P21 (B). All heads (A) and eyes (B) were sectioned and stained with an antibody against BrdU. The TM region (white box) is magnified below each panel. In sections from eyes aged to P21, positive cells within the TM region were quantified. A significant decrease in proliferating TM cells was observed in mice injected with BrdU at P1 and P3 compared to those injected at E15.5 (C). Mean ± SEM is shown in graph. *p < 0.05. An additional proliferation marker, Ki67, was used to confirm the postnatal decrease in proliferation (D). N = 3 animals per time point were collected. Retina (ret), ciliary body (cb), cornea (cor), and lens are indicated in inverted black and white images below for spatial reference. Scale bar represents 100 μM. R.L. Rausch et al. Experimental Eye Research 170 (2018) [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] microscope with Axiovision software.
Bromodeoxyuridine (BrdU) label-retaining assay
For the first BrdU experiment, pregnant dams were intraperitoneally injected with 5 μL/g body weight BrdU (20 mg/mL in 1X PBS) at E15.5 and E17.5 (E0.5 assigned upon detection of vaginal plug). P1 and P3 pups (P0 assigned on day of birth) were injected in the upper hind leg adjacent to the femoral vein using identical concentration and volume calculations. Embryos and pups were sacrificed and decapitated two hours after injection and prepared for histology. For the second BrdU experiment, the same ages were injected twice daily (same dosage) and all animals were aged to P21, at which point they were sacrificed for enucleation. Both heads and eyes were processed as described above. 14 μm cryo-sections were incubated in a 1:1 solution of formamide and 2X saline-sodium citrate (SSC) for 2 h at 65°C, washed with 2X SSC for 10 min at room temperature, washed with 2N HCL at 37°C, washed with 0.1M boric acid for 10 min at room temperature, blocked in 10% horse serum in 0.3% Triton-X in 1XPBS for one hour at room temperature, and incubated in mouse anti-BrdU (Roche) at a concentration of 1:500 shaking overnight at room temperature. The following day, sections were washed with 1XPBS for twice for 20 min at room temperature. A secondary antibody (donkey anti-mouse Alexa Fluor 488; Thermo Fisher Scientific) was used at a concentration of 1:1000 for 2 hours at room temperature.
Slit lamp examination
Imaging of the anterior segment was performed on awake mice using a slit lamp biomicroscope (Topcon) equipped with digital camera (Nikon). ASD was determined by the presence of one or more of the following phenotypes: corneal opacity, iris hypoplasia, pupil displacement, cataracts, microphthalmia, and anophthalmia.
Intraocular pressure measurements
IOP measurements were obtained using the TonoLab tonometer. IOP was recorded following anesthesia administration (intraperitoneal R.L. Rausch et al. Experimental Eye Research 170 (2018) 81-91 injection of ketamine/xylazine mix (5 μL/g)) as previously described (Harder et al., 2012) .
2.7. TM boundary identification, cell counts, and αSMA grading TM area in P1 and P21 mice was outlined in sections with ImageJ using the following anatomical borders: the distal tip of the retina above the pigmented ciliary epithelium (left border), the ciliary muscle (bottom border), approximately halfway down the developing iris (right border), and below the corneal endothelium (top border). Due to the lack of specific markers for the developing TM, the area outlined likely encompassed additional cell types, however the experimenter was masked to genotype and remained as consistent as possible. BrdU + and cCasp3 + cells were counted in P1 sections within the outlined TM area on ImageJ. At least 4 non-consecutive sections from 3 different animals were counted and averaged for each group. αSMA staining in P1 and P10 sections was assessed on a grading scale: robust expression, mild/sporadic expression, and absent expression. At least 3 non-consecutive sections from 3 different animals were graded and the percentage of each category was averaged. Wild-type littermate controls were analyzed separately for Jag1 and Bmp4 heterozygous strains for all analyses except IOP measurement.
Statistical analysis
P values < 0.05 were considered significant for all experimental analysis. Graphpad Prism was used for statistical analyses and graph production. Paired student's t-tests were used to analyze IOP measurements, TM area, and BrdU + and cCasp3 + cell counts between heterozygotes and controls. Chi-squared analysis was used to determine differences in αSMA grading between heterozygotes and controls. Means ± SEM is displayed in graphs. At least 3 animals were assessed per genotype per assay. . αSMA is expressed in the postnatal TM region. C57BL/6J mice were stained with an antibody against αSMA at the indicated ages. Representative images from each time point demonstrate there was no αSMA expression at embryonic ages (A, B). Onset of αSMA expression occurred at P1 (C), and persisted throughout postnatal development in the TM region (white boxes, magnified below each panel, D-H). αSMA expression was also observed in the ciliary muscle and iris sphincter muscle (double headed arrows), visible in several sections at all postnatal time points. N = 3 animals per age. Retina (ret), ciliary body (cb), cornea (cor), and lens are indicated in inverted black and white images below for spatial reference. Scale bar represents 100 μM.
R.L. Rausch et al. Experimental Eye Research 170 (2018) 81-91 3. Results
The iridocorneal angle undergoes distinct morphological alterations at P1
Development of the anterior segment begins following neural crestderived periocular mesenchymal cell migration between the developing cornea and lens at E12.5, though it has been suggested that the anterior chamber and iridocorneal angle structures do not form until ∼ E15 when the corneal endothelium has differentiated (Gould et al., 2004; Reneker et al., 2000) . Structural alterations within the TM continue until around P21, when the tissue is considered essentially mature ). Based upon this information, we began a thorough assessment of TM formation by first analyzing the morphological progression of the TM at eight time points: E15.5, E17.5, P1, P3, P5, P7, P10, and P21 using semi-thin plastic sections stained with hematoxylin and eosin (H&E). The morphological changes observed were similar to previous reports (Gould et al., 2004; Smith et al., 2001) . However, whereas several other groups noted the appearance of a physical chamber angle as early as E15 (Reneker et al., 2000) and E16.5 (Gould et al., 2004 ), we did not observe an obvious angle opening between the corneal endothelium and developing iris until after E17.5 (Fig. 1A-C ). An obvious iridocorneal angle was present by P1, a time point that further coincided with clear changes in mesenchymal cell morphology, including the separation and elongation of periocular mesenchymal cells (Fig. 1C) . The TM, ciliary body, and Schlemm's canal continue to develop postnatally (Fig. 1C-H ). Schlemm's canal is visible in most sections by P21 (arrowhead in Fig. 1H ).
Proliferation of TM precursor cells significantly decreases postnatally
The time point at which prospective TM cells undergo their terminal mitotic division-or even whether these cells permanently leave the cell cycle-is unknown. To analyze the rate and cessation of TM precursor cell proliferation, pregnant dams and perinatal pups were injected with BrdU at the first four time points assessed previously: E15.5, E17.5, P1, and P3. Following tissue collection two hours post BrdU administration, TM sections were stained with an antibody against BrdU. There were several dividing cells in the developing iridocorneal angle of embryonic eyes (E15.5 and E17.5), however very few in the : slit lamp/IOP, n = 12; plastic, n = 3. Bmp4 Δ/+ : slit lamp/IOP, n = 26; plastic, n = 3. *p < 0.05. Scale bar represents 100 μM.
R.L. Rausch et al. Experimental Eye Research 170 (2018) 81-91 presumptive TM area postnatally at P1 and P3 ( Fig. 2A) . This suggested that mesenchymal TM precursor cell proliferation persists in early TM morphogenesis until the majority exit the cell cycle around birth. A caveat to this experiment, however, was the uncertainty that the dividing cells visualized at those stages were in fact future TM cells, as it is possible they migrated from a different area. In order to label dividing cells fated to become mature TM cells, we again performed timed BrdU injections at E15.5, E17.5, P1, and P3, although in this experiment animals were aged to P21 in order to identify mature TM cells (Fig. 2B) . Consistent with the previous findings, the height of examined proliferation was observed in animals injected embryonically at E15.5 with an average of 11.8 ± 1.4 BrdU + cells per TM per section.
The rate of cell division significantly decreased postnatally, with an average of 3 ± 0.17 BrdU + cells per TM per section at P1 (p = 0.0111) and an average of 5.1 ± 1.2 BrdU + cells per TM per section at P3
(p = 0.0414: Fig. 2C ). As BrdU only marks cells undergoing DNA synthesis, we sought to corroborate these findings with an additional marker of proliferation: Ki67, which marks all stages of the cell cycle. Similar to the BrdU experiments, the number of Ki67-positive cells in the TM region decreased from E17.5 to P1 (Fig. 2D) . Importantly, these experiments demonstrated that a few cells were still dividing at postnatal time points in the iridocorneal angle, indicating there may be a low level of continuous TM cell proliferation that was not captured in the shorter harvests. It is also possible that the sub regions of the TM exhibit distinct proliferation profiles (Llobet et al., 2003) .
Caspase3-dependent apoptosis does not play a role in TM formation
Smith et al. reported that cell death does not play a role in mouse TM development ), However, that study only examined mice P12 and older, thus not ruling out the possibility of apoptotic pruning having a role earlier in development, when major differentiation events are likely taking place. In a study examining human fetal eyes, no cell death was observed throughout the entire time course of TM development (Meghpara et al., 2008) . However in rats, necrotic cells were observed postnatally in the developing iridocorneal angle (Remé et al., 1983 ). An older study examining TM development in cats hypothesized that the intercellular spaces formed between trabecular beams are generated primarily by cellular reorganization and enlargement, though a decrease in cell number was observed between 10 and 12 days of age (Richardson et al., 1985) . With the incomplete and variable conclusions reached across species, we aimed to establish whether apoptotic cell death plays a role early in mouse TM development. Eyes were sectioned and stained for cleaved caspase3 (cCasp3), a marker of apoptotic cell death, at E15.5, E17.5, P1, P3, P5, P7, P10, and P21. Aside from the occasional cCasp3 + cell in the developing iridocorneal angle area (Fig. 3A) , it was evident that caspase3-dependent apoptotic cell death does not play a significant role in early TM development, or in the subsequent formation of intertrabecular spaces among ECM beams (Fig. 3) .
3.4. αSMA expression emerges at P1 and persists throughout development αSMA, though not exclusively expressed in TM cells, is a common marker used to identify the adult TM (de Kater et al., 1992; Ko and Tan, 2013; Zhao et al., 2013) . To our knowledge, no one has identified the onset of αSMA expression in the developing TM. In order to determine the spatiotemporal expression pattern throughout TM morphogenesis, we stained for αSMA on ocular sections from E15.5, E17.5, P1, P3, P5, P7, P10, and P21 mice (Fig. 4) . At E15.5 and E17.5, no detectable αSMA was present in the developing iridocorneal angle (Fig. 4A and B) . However at P1, αSMA expression appeared within the prospective TM, as well as the ciliary muscle and iris sphincter muscle (Fig. 4C) . Interestingly, the timing of αSMA onset appears to coincide with the iridocorneal angle opening and TM precursor cell elongation/separation displayed in Fig. 1C as well as the decrease in TM cell proliferation (Fig. 2) . Persistent αSMA expression is detected in the TM at all remaining time points examined (Fig. 4D-H) , signifying the use for this marker in longitudinally examining postnatal TM dysgenesis in mouse models of ASD.
Mouse models of ASD display iridocorneal adhesions, TM hypoplasia, and variable IOP
To apply our novel TM development findings from wild-type C57BL/6J mice, we next assessed two mouse models of ASD: Bmp4 heterozygous null (Bmp4 Δ/+ ) and Jag1 heterozygous null (Jag1 Δ/+ ) mice. While ASD in Bmp4 Δ/+ mice has been established previously (Chang et al., 2001) , the anterior segment of Jag1 Δ/+ mice, though formerly shown to exhibit pupil displacement (Kiernan et al., 2007) , has not been thoroughly examined. Multiple ASD phenotypes are present in both mutants, including pupil dysmorphology in Jag1 Δ/+ mice, Fig. 7 . Morphological defects are detected in both Jag Δ/+ and Bmp4 Δ/+ mutants at P5 and P10. H&E staining on 3 μM thick plastic sections from both mutants at P5 (A-F) and P10 (G-L)
show varying levels of iridocorneal adhesions, ciliary body hypoplasia, and TM dysgenesis. Iridocorneal adherence appears to progress with age, though variability exists at both ages in all eyes examined (differences in angle closure seen in B&C, E&F, H&I, and K&L). R.L. Rausch et al. Experimental Eye Research 170 (2018) [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] iris hypoplasia in Bmp4 Δ/+ mice, and ciliary body hypoplasia in both Jag1 Δ/+ and Bmp4 Δ/+ mice (Fig. 5) . Of particular interest, both mutants also display iridocorneal adhesions, absence of Schlemm's canal, and a hypoplastic or absent TM, though these phenotypic presentations are highly variable both between and within eyes ( Fig. 5F, H) . To determine whether aberrant TM histology correlated with ocular hypertension in these mutants, we assessed intraocular pressure (IOP) on adult mice (Fig. 5I) : 13.52 ± 1.15 mmHg; p = 0.92). This is perhaps unsurprising as the presence of TM dysgenesis does not always predict elevated IOP (Howell et al., 2008) . Differences in genetic background might also explain the variability in IOP (Chang et al., 2001; Kiernan et al., 2007; Mao et al., 2015) , as the Bmp4 Δ/+ mice were maintained on a C57BL/6J background and the Jag1 Δ/+ mice were maintained on a mixed background. While there are obvious similarities between Jag1 Δ/+ and Bmp4 Δ/+ mice concerning TM morphological aberrations, it is possible that unique developmental disruptions cause molecular or microstructural differences in the anterior segments of these two mutants.
3.6. TM dysgenesis does not result from decreased proliferation or increased cell death at P1 in Jag1 Δ/+ or Bmp4 Δ/+ mice To elucidate the developmental mechanisms responsible for causing TM dysgenesis in Jag1 Δ/+ and Bmp4 Δ/+ mice, we first examined presumptive TM area, proliferation, apoptotic cell death, and αSMA expression in both mutants at P1. This time point was chosen as it marked the stage at which (1) significant morphological changes were apparent, (2) cell division significantly decreased, and (3) αSMA expression appeared (Figs. 1, 2 and 4) . The presumptive TM area was outlined by a masked experimenter using anatomical borders (see methods). The average TM area was significantly decreased in Jag1 mutants (Jag1 +/+ : 6938 ± 737.9 μM : 7517 ± 810.5 μM 2 ; p > 0.05) each compared to its own littermate controls at P1 (Fig. 6A-D, M) .
As E15.5 marked the height of TM precursor cell proliferation in wild-type animals (Fig. 2) , we injected pregnant dams from both strains with BrdU at E15.5 and harvested the tissue at P1, ensuring morphological consistency throughout our analysis (Fig. 6E-H, N) . Quantification of BrdU + cells revealed no differences in either Jag1 Δ/+ or Bmp4 Δ/+ mice when compared to littermate controls (Jag1 : 21.9 ± 3.5 cells per section; both p > 0.05). Δ/+ and Bmp4 Δ/+ mutants at P1 and P10. αSMA expression in the TM region (white boxes) was variable among wild-type littermate controls of both strains at P1 (A, C), however a significant decrease in αSMA expression was found in both mutants at this age (B, D, E). αSMA expression was less variable at P10 in wild-type littermate controls than at P1 (F, I ). Both mutants demonstrate significantly fewer regions of robust αSMA at P10 (G, H, J, K, L), similar to the levels seen in P1 mutants. Staining was assessed by ratings of "robust", "mild", or "absent" by a masked experimenter. Average percentage of each grading category is displayed in graphs analyzed by chi-squared test (M). N = 3 per genotype. Scale bars represent 100 μM.
R.L. Rausch et al. Experimental Eye Research 170 (2018) 81-91 Very little cCasp3 was observed in wild-type controls, however it was possible that apoptotic cell death was responsible for TM malformation the ASD mutants (Fig. 6I-L 3.7. TM dysgenesis is evident at P5 and P10 in both Jag1
Δ/+ and Bmp4
Aside from the smaller presumptive TM area in the Jag1 Δ/+ mice, there were no major histological differences in either ASD mutant at P1. We therefore chose to analyze both mutants at later time points in TM development. In another mouse model of ASD, the Col4a1 mutant was indistinguishable from littermate controls at E18.5, but displayed iridocorneal abnormalities at P10 (Gould et al., 2007) . Interestingly, we found similar results in both the Jag1 Δ/+ and Bmp4 Δ/+ mutants. At P5
and P10, both mutants demonstrated iridocorneal adhesions and TM hypoplasia, along with impaired ciliary body formation (Fig. 7) . Some areas of the iridocorneal angle within both mutants displayed less severe dysgenesis, though iridocorneal adhesions always appeared to at least somewhat block the TM tissue (Fig. 7B , C, E, F, H, I, K, L).
3.8. αSMA expression is decreased in Jag1 Δ/+ and Bmp4 Δ/+ mice at P1
and P10
Based upon these results, it appears that the TM dysgenesis evident by P5 in both Jag1 Δ/+ and Bmp4 Δ/+ mice is not due to a decrease in TM precursor cell proliferation or an increase in cleaved caspase3-dependent apoptotic cell death at P1. It therefore may be a result of impaired TM differentiation. To determine if this is the case, we performed immunohistochemical analysis of αSMA on both mutants at P1 (when αSMA expression becomes evident) and P10, to examine levels of expression. While αSMA expression is variable around the circumference of the eye in wild-type controls at P1, likely because TM cells are just beginning to express this marker, there was a significant decrease in robust staining in both Jag1 Δ/+ and Bmp4 Δ/+ mutants ( Fig. 8A-E) .
Interestingly, there were still areas of the TM in both mutants with mild or robust αSMA expression (Fig. 8E) , suggesting that TM hypoplasia is not uniform around the iridocorneal angle circumference. We further stained a separate cohort of P10 Jag1 Δ/+ and Bmp4 Δ/+ mutants with αSMA to examine whether the differences seen in P1 were more pronounced at this later time point. In wild-type controls, all animals displayed primarily robust expression around the circumference of the eye (Fig. 8F, I , L). Similar to the P1 results, both mutants had significantly fewer areas of robust staining compared to controls at P10, though with considerable variability between and within mutant iridocorneal angles (Fig. 8G , H, J, K, L).
Discussion
This work has demonstrated multiple previously unreported characteristics of normal trabecular meshwork development and identified key stages of TM differentiation. Changes in TM precursor cell shape and distribution, physical iridocorneal angle emergence, a decrease in cell division, and onset of αSMA expression all occur at P1, indicating an important stage in TM morphogenesis. Furthermore, we have shown that despite inconsistencies among species, caspase3-dependent apoptotic cell death does not appear to play a role in murine TM formation. Application of these findings to two mouse models of ASD led to the conclusion that TM defects observed in adults are not due to decreased proliferation or increased cell death at P1. It appears that these mouse models have impaired TM cell differentiation during early postnatal development, as evidenced by a decrease in αSMA staining at P1 and P10 in both mutants.
There are several possible ways in which heterozygous mutations in Bmp4 and Jag1 could result in TM hypoplasia. The TM progenitor pool may be reduced, downstream genes required for differentiation may be delayed or downregulated, or morphogenesis could be physically inhibited by iridocorneal adhesions. As the TM is one of the last structures to form, its maldevelopment could also occur as a secondary effect from another ASD phenotype. Both Jag1 Δ/+ and Bmp4 Δ/+ mutants display additional abnormalities in the ciliary body, Schlemm's canal, and cornea. Reneker and colleagues found that their mouse models of ASD (expressing either TGFα or EGF in the lens) had impaired corneal endothelial differentiation which subsequently contributed to corneal adhesions to both the iris and the lens, thereby preventing TM formation (Reneker et al., 2000) . Others have suggested that signals emanating from the lens and/or corneal epithelium facilitate the morphogenesis of the iridocorneal angle tissues (Kroeber et al., 2010; Li et al., 2016) . For example deletion of Pax6 from the lens, but not from the peripheral optic cup, resulted in severe TM hypoplasia, iridocorneal adhesions, and increased IOP (Kroeber et al., 2010) . Mice presenting with ASD (in addition to the Jag1 Δ/+ and Bmp4 Δ/+ mutants examined in this study) often have concurrent iridocorneal adhesion and TM malformation. However, which of these phenotypes occurs first and conceivably causes the other is difficult to dissect. Each tissue affected in an iridocorneal adhesion -cornea, iris, and TM -is completely or partially derived from neural crest origin (TM; corneal endothelium and stroma; iris stroma) (Williams and Bohnsack, 2015) . The cranial neural crest cells that form these tissues are believed to remain undifferentiated following their final wave of migration into the anterior segment of the eye before birth (Gage et al., 2005; Williams and Bohnsack, 2015) . It has been postulated that abnormal migration of neural crest cells underlies the maldevelopment of structures affected in ASD (Williams and Bohnsack, 2015) . This might be the case in the Jag1 Δ/+ mutants, as the TM area was significantly smaller at P1. In the Bmp4 Δ/+ mutants, however, we did not observe a decrease in cell density or in the number of proliferating cells within the presumptive TM at P1, suggesting a subsequent impairment in TM differentiation throughout early postnatal development. Thus, despite the two mutants exhibiting highly similar P5, P10, and adult ASD phenotypes, it appears that defects in TM cell migration, rather than, or possibly in addition to, defects in TM differentiation might cause the dysgenesis in Jag1 Δ/+ mutants. In the Bmp4 Δ/+ mutants, however, it seems as though the neural crest-derived TM precursor cells arrive at their final destination but subsequently fail to differentiate properly. The significant reduction in αSMA expression observed at P1 prior to overt physical dysgenesis is consistent with anomalous migration or differentiation. In the Col4a1 heterozygous mutant mouse model of ASD, a normal physical chamber angle is observed at E18.5, whereas by P10, iridocorneal adhesions are present along with maldevelopment of the TM (Gould et al., 2007) . Similar morphological aberrations were seen in both the Jag1 Δ/+ and Bmp4 Δ/+ mutants, whereby severe TM dysgenesis and iridocorneal adhesions were not detected until P5 and appeared to worsen by P10. Based on these collective findings, it is possible that abnormal postnatal TM differentiation leads to subsequent iris collapse causing iridocorneal adhesions in the anterior chamber. The observed decrease in αSMA staining at P1 is consistent with the idea that early defects in the differentiation or migration of TM cells contribute to the formation of the iridocorneal adhesions that develop later. In another model of ASD, however, adhesions were observed as early as E16, and completely prevented the formation of an anterior chamber (Reneker et al., 2000) . The iridocorneal defects in ASD mouse models with overt embryonic adhesions are believed to be due to an earlier defect in which the surface ectoderm fails to fully detach from the developing optic cup, thereby preventing neural crest cell migration into the iridocorneal angle. Thus, there may be multiple causative mechanisms leading to TM hypoplasia and iridocorneal adhesions, highlighting the need for the discovery of TM-specific molecular markers. The challenge of finding novel markers for this important tissue is made even more complicated by the fact that the TM is subdivided into three regions. The juxtacanalicular (JCT) region, thought to be responsible for the resistance of aqueous outflow, differs both structurally and functionally from the uveal and corneoscleral regions (Keller and Acott, 2013) . While only one protein (αΒ-crystallin) has thus far been identified as expressed exclusively in the JCT compared to the other two regions, it is likely that many differentially expressed genes exist between these heterogeneous regions (Keller and Acott, 2013; Llobet et al., 2003) . They may also have unique proliferation and differentiation timelines, as suggested by our BrdU-labeling experiments. Identifying cellular markers exclusive to TM tissue-and specific to each sub region of TM tissue-is not only important for uncovering developmental disease mechanisms, but also for the advancement of cell replacement therapy for patients suffering from diseases like adultonset primary open angle glaucoma (Sathiyanathan et al., 2017) . Understanding and identifying differentiation and mature markers for TM cells are critical requirements for developing stem and iPS cell approaches.
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